Cardiac Cachexia: Unaddressed Aspect in Cancer Patients.

Cardiac Cachexia: Unaddressed Aspect in Cancer Patients.
复制标题

DOI:
10.3390/cells11060990
复制
发表时间:
2022-03-14
期刊:
影响因子:
6
通讯作者:
Kakar SS
Kakar SS
中科院分区:
生物学2区
文献类型:
--
作者:
Saha S;Singh PK;Roy P;Kakar SS

文献摘要

参考文献

相似文献

肿瘤源性恶病质因子,如促炎细胞因子和神经调节剂,不仅影响骨骼肌,还影响其他器官,包括心脏,以心肌萎缩、纤维化和最终心脏功能障碍的形式,导致生活质量差和生存率降低。本文回顾了现有的诊断、病理生理学和多模式治疗干预的整体方法,针对癌症引起的心脏恶病质的分子机制。癌症患者心肌萎缩的主要驱动因素是细胞因子-NFkB、TGF β-SMAD3 和血管紧张素 II-SOCE-STIM-Ca2+ 途径的自噬激活。缺乏诊断标志物和标准治疗方案阻碍了心功能障碍的早期诊断和预防措施的启动。然而,一些新的治疗策略,包括使用 Withaferin A,已在实验模型中显示出有希望的结果,但 Withaferin A 在人体中的有效性仍有待验证。心脏病学家和肿瘤学家的共同努力将有助于找到具有成本效益且可行的解决方案,以恢复心脏功能并提高癌症患者的生存潜力。
Tumor-derived cachectic factors such as proinflammatory cytokines and neuromodulators not only affect skeletal muscle but also affect other organs, including the heart, in the form of cardiac muscle atrophy, fibrosis, and eventual cardiac dysfunction, resulting in poor quality of life and reduced survival. This article reviews the holistic approaches of existing diagnostic, pathophysiological, and multimodal therapeutic interventions targeting the molecular mechanisms that are responsible for cancer-induced cardiac cachexia. The major drivers of cardiac muscle wasting in cancer patients are autophagy activation by the cytokine-NFkB, TGF β-SMAD3, and angiotensin II-SOCE-STIM-Ca2+ pathways. A lack of diagnostic markers and standard treatment protocols hinder the early diagnosis of cardiac dysfunction and the initiation of preventive measures. However, some novel therapeutic strategies, including the use of Withaferin A, have shown promising results in experimental models, but Withaferin A’s effectiveness in human remains to be verified. The combined efforts of cardiologists and oncologists would help to identify cost effective and feasible solutions to restore cardiac function and to increase the survival potential of cancer patients.
DOI: 10.1155/2015/182872
发表时间: 2015
影响因子: 4.6
作者:
Argilés JM;Stemmler B;López-Soriano FJ;Busquets S
通讯作者: Busquets S
DOI: 10.1378/chest.54.5.403
发表时间: 1968-01-01
期刊: DISEASES OF THE CHEST
影响因子: --
作者:
BURCH, GE;PHILLIPS, JH;ANSARI, A
通讯作者: ANSARI, A
DOI: 10.1016/s0735-1097(00)00748-8
发表时间: 2000-08-01
影响因子: 24
作者:
Cardinale, D;Sandri, MT;Fiorentini, C
通讯作者: Fiorentini, C
DOI: 10.1371/journal.pone.0175544
发表时间: 2017
期刊: PloS one
影响因子: 3.7
作者:
Boyd A;Stoodley P;Richards D;Hui R;Harnett P;Vo K;Marwick T;Thomas L
通讯作者: Thomas L
DOI: 10.3389/fphar.2021.694762
发表时间: 2021
影响因子: 5.6
作者:
Albini A;Festa MMG;Ring N;Baci D;Rehman M;Finzi G;Sessa F;Zacchigna S;Bruno A;Noonan DM
通讯作者: Noonan DM